Gaining insights into inflammatory bowel disease through mass cytometry and Imaging Mass Cytometry analysis of the human mucosal immune system Research aimed at more precise treatments for IMIDs using existing therapies and identification of new targets for drug development SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ: FLDM) today announced it is one of 11 partners in the TIMID Consortium, a […]

SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ: FLDM) and Indica Labs, Inc., today announced a co-marketing relationship for scalable and simple-to-use tissue image analysis for Imaging Mass Cytometry™ (IMC™). Under the terms of the agreement, Fluidigm and Indica Labs will cooperatively promote the next-generation digital pathology image analysis and image management platforms HALO®, HALO AI™ and HALO Link™ in conjunction with the Fluidigm® Hyperion™ Imaging System, MCD™ Viewer […]

Walkersville, MD (USA) – Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range of hematopoietic primary cells. This partnership expands Lonza’s broad offering of hematopoietic cell lines and enables cell biologists to easily access a wide selection of high-quality cells to boost their scientific research. […]

New innovations in Invitrogen EVOS M7000 microscope include high-end camera and more powerful computer CARLSBAD, Calif. — For biological researchers requiring high-quality images and data from their cells and samples without over-investing time and resources to get them, the fully automated Invitrogen EVOS M7000 microscope features a high-end camera and more powerful computer to deliver better […]

INTEGRA has responded to customers’ requests and developed two new 24-channel pipetting heads, extending the capabilities of its popular VIAFLO 96/384. Designed to make cell biology workflows more efficient and reliable, these handheld electronic pipettes allow plate filling, reagent addition or sample transfers to be performed in a single step, enabling quicker and more accurate […]

Biologic drugs are precision medicines which have revolutionised the treatment of chronic diseases such as cancer and inflammatory disorders. However, there are significant manufacturing challenges in translating these therapies to the market, due to a complex, time-consuming and labour-intensive manufacturing process. Andrew Alliance S.A., the robotics company that is improving laboratory workflow execution through the […]

In January 2019 Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, announced a technology partnering and collaboration agreement to enable rapid, high expression, stable cell line development. But what exactly are the tangible benefits gained from both parties and for customers, and why does this fusion of technology offer more […]

VICTORIA / – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) has announced the purchase of its second state-of-the-art Intellicyt® iQue Screener PLUS for high-throughput cell-based screening. The demand for accelerated development of next-generation antibodies that recognize evermore challenging targets and have improved activities has prompted IPA to purchase further instrumentation […]

The REPROCELL group has signed a non-exclusive distributorship agreement with RUITAI Biotechnology (Shanghai) Ltd to distribute REPROCELL’s products in China. Through the RUITAI group’s offices in Shanghai, Hangzhou, and Shenyang, and combining with existing distributors in China, the agreement aims to broaden the reach of the products of the REPROCELL group to researchers and scientists […]